Buy at $495: Staged 2.5–3% portfolio accumulation into 200 SMA/Lower BB confluence with three-trigger tranche system
Buy rating justified by $1.263T assets, $365.5B liquid securities (34% of market cap), $71.98B TTM free cash flow, 32.6% operating margins, 0.607 beta, Aaa rating, and $4.21B Q2 buyback resumption under Greg Abel. Macro regime (30Y yields >5%, 85% no-cut probability, $40T federal debt) structurally enhances insurance float carry. The 200 SMA ($492.12) and Lower BB ($490.34) confluence zone represents high-probability mean-reversion entry. Forward P/E of 22.34 and Alphabet concentration risk (29.7% of equity book, 83% stake increase in single quarter) prevent Overweight despite strong structural case, supporting a measured Buy with disciplined tranche execution.
| Position | Action |
|---|---|
| Initial tranche | 1% at spot ($495) |
| Close >$500.39 with RSI >45 and MACD histogram flattening | 1% second tranche |
| 50 SMA retest from above | 1% final tranche |
| Total portfolio allocation | 2.5–3% maximum |
Berkshire Hathaway at $495 represents a high-quality entry point backed by $365.5B in cash generating elevated yields in a structurally favorable macro regime, with Q2 2026 earnings showing exceptional strength and Greg Abel's strategic pivot into AI providing secular growth catalyst.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 503.30 | bearish |
| 50 SMA | 500.39 | neutral |
| 200 SMA | 492.12 | bullish |
| RSI (14) | 41.97 | bearish |
| MACD | -0.20 | bearish |
| MACD Histogram | -2.93 | bearish |
| Bollinger Middle Band (20 SMA) | 509.79 | neutral |
| Bollinger Upper Band | 529.24 | neutral |
| Bollinger Lower Band | 490.34 | bullish |
| ATR (14) | 7.49 | neutral |
| Close |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close >$500.39 with RSI >45 and MACD histogram first signs of flattening
Then: 1% tranche
Q2 2026 earnings were exceptional across all metrics, demonstrating real earnings quality
EV: +6.9% · concedes: Forward P/E of 22.34 is elevated relative to TTM P/E of 12.47 due to non-recurring investment gains; Short-term momentum is bearish with negative MACD and lost 50 SMA; Post-Buffett succession risk is real though Q2 demonstrated execution capability; OMAH ETF passive outflows create mechanical selling pressure; YTD performance has lagged S&P 500
BRK-B at $495 is a value trap, not a gift—the forward P/E of 22.34 signals earnings normalization, net debt tripled YoY, the "defensive" thesis is already priced in (+0.81% YTD), and 29.7% concentration in two AI stocks destroys defensive credibility while buyback pace reveals management lacks conviction.
· concedes: The $175B cash position does generate meaningful carry (~$15-18B annually); Insurance float of ~$165B at near-zero cost remains a structural advantage, though narrower than before; Berkshire's operating businesses have genuine diversification benefits; The long-term compounding track record under Buffett is historically exceptional
→ vs conservative: Forward P/E of 22.34 appears elevated but reflects Wall Street's conservative earnings modeling; actual Q2 2026 performance (EPS 11.91 annualized, net income 25.67B, revenue +19.2%) validates higher intrinsic value
→ vs conservative: MACD below zero and RSI at 42 represent the entire bearish case playing out at exactly the level where it should fail; broken momentum is coincident not leading
→ vs neutral: Waiting for daily close above 50 SMA at 500.39 means buying at the momentum premium after the mean-reversion trade at 492 has already moved 1.6%; the easy 2:1 risk-reward disappears during the confirmation wait
→ vs conservative: Alphabet concentration is a consensus signal (Buffett, Druckenmiller, Abel all independently validated) not a risk; 3-5% book value exposure vs fortress balance sheet asymmetry massively favors longs
→ vs neutral: The 'wait for confirmation' strategy made investors miss Apple at 35 in 2016, Microsoft at 40 in 2015, and Berkshire at 80 in 2009; buy the test, don't chase the reclaim
| 495.82 |
| neutral |
| Open | 498.50 | neutral |
| High | 501.00 | neutral |
| Low | 495.68 | neutral |
| Volume | 4,620,603 | neutral |
Support: 490.34 · 492.12 · 464 · 465 · 466 · 467 · 468 | Resistance: 529.42 · 503.3 · 500.39 · 510 · 520
BRK-B exhibits short-term bearish momentum (price below 10 EMA and 50 SMA, MACD below zero, RSI declining from 74.55 peak to 41.97) while maintaining long-term bullish structure (price above rising 200 SMA at 492.12). The stock is positioned at a critical support confluence zone between 490.34 (Bollinger Lower Band) and 492.12 (200 SMA), historically a potential bounce area, but lacks the momentum washout typically required for a high-confidence long entry. ATR has expanded 17% to 7.49, warranting reduced position sizing. The recommended posture is HOLD pending a reclaim above 500.39 (50 SMA) for bullish resolution or a daily close below 490.34 for bearish confirmation.
Market Capitalization
$1.061 Trillion
P/E Ratio (TTM)
12.47
Forward P/E
22.34
EPS (TTM)
$39.75
Forward EPS
$22.19
Beta
0.607
Revenue (TTM)
$384.69B
Net Income (TTM)
$85.77B
Profit Margin
22.3%
Operating Margin
32.6%
ROE
12.12%
ROA
6.01%
Total Assets
$1.263T
Cash & ST Investments
$365.51B
Equity Investments
$323.78B
Total Stockholders Equity
$747.91B
Tangible Book Value
$630.79B
Long-Term Debt
$125.94B
Net Debt
$88.0B
TTM Free Cash Flow
$71.98B
Q2 2026 FCF
$5.57B
Q2 2026 Buybacks
$4.21B
Q2 2026 Revenue YoY Growth
+19.2%
Q2 2026 Net Income YoY Growth
+107.5%
52-Week High
$537.74
52-Week Low
$464.01
50-Day Moving Average
$500.15
200-Day Moving Average
$492.02
Q2 2026 Net Income
$25.67B
Q2 2026 Diluted EPS
$11.91
Debt-to-Equity Ratio
17.14
Strengths
Concerns
HOLD with bullish bias - BRK-B remains a core defensive holding with attractive risk-adjusted characteristics. Near ~$495, valuation is reasonable but not deeply discounted. The combination of low beta (0.607), massive liquidity ($365.5B cash), fortress balance sheet ($1.263T assets, $747.9B equity), and resumed buybacks supports a constructive view. Exceptional Q2 2026 earnings beat with net income doubling YoY suggests near-term upside as the market digests results. Suitable for accumulation on dips toward 200-day MA ($492) or 52-week low ($464) for long-term compounding.